WHYUS
We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.
NewsEvents
IRBM publishes in Nature Scientific Reports on the Janus effect of glucocorticoids on the differentiation of muscle fibro/adipogenic progenitors
30 March 2020
Fibro-adipogenic progenitors (FAPs) are known to cause muscle impairment in non-physiological settings, such as aging and myopathies, by promoting fibrosis…
IRBM shares their experience on developing and maintaining business continuity plans during the COVID19 outbreak
18 March 2020
As the world is coming to terms with the terrific speed of the COVID19 pandemic and how it can dramatically…
IRBM comparte su experiencia en el desarrollo y mantenimiento de planes de continuidad para las empresas durante el brote de COVID19
18 March 2020
En este momento en el que el mundo se enfrenta a la tremendamente rápida difusión de la pandemia de Covid-19…
IRBMPHOTOS
